Skip to content
HowShorted

Lifevantage Corporation short interest in 2025

In 2025, Lifevantage Corporation's disclosed short interest ran from 1.52% of shares outstanding on 15 Jan 2025 to 20.31% on 31 Dec 2025, a change of +18.79 percentage points. The year's high was 20.31% on 31 Dec 2025 and its low 1.52% on 15 Jan 2025, averaging 15.49% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 32.37 days on 15 Aug 2025. Full history: Lifevantage Corporation.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Lifevantage Corporation in 2025

2025 in figures

Start of year
1.52% (15 Jan 2025)
End of year
20.31% (31 Dec 2025)
Change
+18.79 pp
High
20.31% (31 Dec 2025)
Low
1.52% (15 Jan 2025)
Average
15.49%
Highest days to cover
32.37 (15 Aug 2025)
SEC filings marked
8

Every report in 2025

Lifevantage Corporation short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 20251.52%1.00
14 Feb 202511.26%3.0410-Q filed, results (8-K)
28 Feb 202512.50%7.33
14 Mar 202512.71%9.55
31 Mar 202512.10%8.56
15 Apr 202513.85%10.29
30 Apr 202516.23%12.31
15 May 202514.12%6.8010-Q filed, results (8-K)
30 May 202515.84%13.34
13 Jun 202516.40%22.39
30 Jun 202517.82%9.13
15 Jul 202517.91%16.01
31 Jul 202518.78%17.52
15 Aug 202518.62%32.37
29 Aug 202519.70%22.48
15 Sep 202518.30%10.4210-K filed, results (8-K)
30 Sep 202515.48%11.30
15 Oct 202513.97%14.90
31 Oct 202513.69%14.20
14 Nov 202517.06%9.4110-Q filed, results (8-K)
28 Nov 202519.09%15.45
15 Dec 202519.01%15.35
31 Dec 202520.31%12.24

See also: Lifevantage Corporation's full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.